PAI
Palo Alto Investors Portfolio holdings
AUM $470M
1-Year Return
2.57%
This Quarter Return
+16.8%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$2.5B
AUM Growth
+$164M
(+7%)
Cap. Flow
-$121M
Cap. Flow
% of AUM
-4.85%
Top 10 Holdings %
Top 10 Hldgs %
71.22%
Holding
36
New
–
Increased
18
Reduced
2
Closed
–
Top Buys
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$46.3M |
| 2 |
Karyopharm Therapeutics
KPTI
|
+$16.7M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$6.28M |
| 4 |
SAGE
Sage Therapeutics
SAGE
|
+$2.22M |
| 5 |
Insmed
INSM
|
+$1.82M |
Top Sells
| 1 |
ABMD
Abiomed Inc
ABMD
|
+$187M |
| 2 |
Align Technology
ALGN
|
+$11.7M |
Sector Composition
| 1 | Healthcare | 91.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Rigel Pharmaceuticals
RIGL
$660M
| $11.2M | 0.45% |
396,609
| – | – |
|
|
DRNA
27
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $6.14M | 0.25% |
500,913
| – | – |
|
|
ALIM
28
DELISTED
Alimera Sciences, Inc.
ALIM
| $2.95M | 0.12% |
200,920
| – | – |
|
|
VIRX
29
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $2.46M | 0.1% |
33,214
| – | – |
|
|
ZGNX
30
DELISTED
Zogenix, Inc.
ZGNX
| $1.3M | 0.05% |
29,500
| – | – |
|
31
Cytokinetics
CYTK
$5.94B
| $1.03M | 0.04% |
123,686
| – | – |
|
|
ACGN
32
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $814K | 0.03% |
4,537
| – | – |
|
33
Ocugen
OCGN
$372M
| $757K | 0.03% |
5,049
| – | – |
|
|
SPHS
34
DELISTED
Sophiris Bio, Inc.
SPHS
| $694K | 0.03% |
247,000
| – | – |
|
|
TRVN
35
DELISTED
Trevena, Inc.
TRVN
| $491K | 0.02% |
546
| – | – |
|
|
MLNT
36
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
| $322K | 0.01% |
10,138
| – | – |
|